JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1994; 23:1004-1008
© 1994 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Boer, M.
Right arrow Articles by Zijlstra, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Boer, M.
Right arrow Articles by Zijlstra, F

Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction

MJ de Boer, JC Hoorntje, JP Ottervanger, S Reiffers, H Suryapranata, and F Zijlstra

Department of Cardiology, Hospital de Weezenlanden, Zwolle, The Netherlands.

OBJECTIVES. The purpose of the present study was to compare intravenous streptokinase therapy with immediate coronary angioplasty without antecedent thrombolytic therapy with regard to left ventricular function and hospital mortality and reinfarction. BACKGROUND. Despite the widespread use of intravenous thrombolytic therapy and immediate percutaneous transluminal coronary angioplasty, these two strategies to treat patients with an acute myocardial infarction have only recently been compared in randomized trials. Coronary angioplasty has been shown to result in a higher patency rate of the infarct-related coronary artery, with a less severe residual stenotic lesion, compared with streptokinase therapy, but whether this more favorable coronary anatomy results in clinical benefit remains to be established. METHODS. We studied 301 patients with acute myocardial infarction randomly assigned to undergo immediate coronary angioplasty without antecedent thrombolytic therapy or to receive intravenous streptokinase therapy. Before discharge left ventricular ejection fraction was measured by radionuclide scanning. RESULTS. The in-hospital mortality rate in the streptokinase group was 7% (11 of 149 patients) compared with 2% (3 of 152 patients) in the angioplasty group (p = 0.024). In the streptokinase group recurrent myocardial infarction occurred in 15 patients (10%) versus in 2 (1%) in the angioplasty group (p < 0.001). Either death or nonfatal reinfarction occurred in 23 patients (15%) in the streptokinase group and in 5 patients (3%) in the angioplasty group (p = 0.001). Left ventricular ejection fraction was 44 +/- 11% (mean +/- SD) in the streptokinase group versus 50 +/- 11% in the angioplasty group (p < 0.001). CONCLUSIONS. These findings indicate that immediate coronary angioplasty without antecedent thrombolytic therapy results in better left ventricular function and lower risk of death and recurrent myocardial infarction than treatment with intravenous streptokinase.


This article has been cited by other articles:


Home page
HeartHome page
C. Asseburg, Y. Bravo Vergel, S. Palmer, E. Fenwick, M. de Belder, K. R Abrams, and M. Sculpher
Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis
Heart, October 1, 2007; 93(10): 1244 - 1250.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. R Timmer, J. P. Ottervanger, K. Thomas, J. C.A Hoorntje, M.-J. de Boer, H. Suryapranata, F. Zijlstra, and on behalf of the Zwolle myocardial infarction stud
Long-term, cause-specific mortality after myocardial infarction in diabetes
Eur. Heart J., June 1, 2004; 25(11): 926 - 931.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Constantinides, T S N Lo, M Been, and M F Shiu
Early experience with a helical coronary thrombectomy device in patients with acute coronary thrombosis.
Heart, May 1, 2002; 87(5): 455 - 460.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
G. Kabakci, O. Onalan, M. Kemal Batur, A. Yildirir, R. Cagrikul, T. Acil, L. Tokgozoglu, A. Oto, F. Ozmen, and S. Kes
What is the Optimal Evaluation Time of the QT Dispersion After Acute Myocardial Infarction for the Risk Stratification?
Angiology, July 1, 2001; 52(7): 463 - 468.
[Abstract] [PDF]


Home page
CirculationHome page
D. A. Taira, T. B. Seto, K. K. L. Ho, H. M. Krumholz, D. E. Cutlip, R. Berezin, R. E. Kuntz, and D. J. Cohen
Impact of Smoking on Health-Related Quality of Life After Percutaneous Coronary Revascularization
Circulation, September 19, 2000; 102(12): 1369 - 1374.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. B. Berger, S. G. Ellis, D. R. Holmes Jr, C. B. Granger, D. A. Criger, A. Betriu, E. J. Topol, and R. M. Califf
Relationship Between Delay in Performing Direct Coronary Angioplasty and Early Clinical Outcome in Patients With Acute Myocardial Infarction : Results From the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IIb) Trial
Circulation, July 6, 1999; 100(1): 14 - 20.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
C. M. Gibson
Primary Angioplasty Compared with Thrombolysis: New Issues in the Era of Glycoprotein IIb/IIIa Inhibition and Intracoronary Stenting
Ann Intern Med, May 18, 1999; 130(10): 841 - 847.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Garcia, J. Elizaga, N. Perez-Castellano, J. A. Serrano, J. Soriano, M. Abeytua, J. Botas, R. Rubio, E. Lopez de Sa, J. L. Lopez-Sendon, et al.
Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction
J. Am. Coll. Cardiol., March 1, 1999; 33(3): 605 - 611.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. J. Brener, L. A. Barr, J. E. B. Burchenal, S. Katz, B. S. George, A. A. Jones, E. D. Cohen, P. C. Gainey, H. J. White, H. B. Cheek, et al.
Randomized, Placebo-Controlled Trial of Platelet Glycoprotein IIb/IIIa Blockade With Primary Angioplasty for Acute Myocardial Infarction
Circulation, August 25, 1998; 98(8): 734 - 741.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. W. Stone, C. L. Grines, W. W. O'Neill, V. Pasceri, S. G. Ellis, E. J. Topol, A. Betriu, and R. M. Califf
Primary Coronary Angioplasty versus Thrombolysis
N. Engl. J. Med., October 16, 1997; 337(16): 1168 - 1170.
[Full Text]


Home page
NEJMHome page
N. R. Every, L. S. Parsons, M. Hlatky, J. S. Martin, W. D. Weaver, and The Myocardial Infarction Triage and Intervention
A Comparison of Thrombolytic Therapy with Primary Coronary Angioplasty for Acute Myocardial Infarction
N. Engl. J. Med., October 24, 1996; 335(17): 1253 - 1260.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. W. Kennedy
Optimal Management of Acute Myocardial Infarction Requires Early and Complete Reperfusion
Circulation, April 1, 1995; 91(7): 1905 - 1907.
[Full Text]


Home page
CLIN APPL THROMB HEMOSTHome page
F. Leya, J. Fareed, and J. Walenga
Acute Myocardial Infarction: Diagnosis and Management
Clinical and Applied Thrombosis/Hemostasis, March 1, 1995; 1(2): 160 - 165.
[Abstract] [PDF]


Home page
BMJHome page
J McMurray and A Rankin
Recent Advances: Cardiology - I: Treatment of myocardial infarction, unstable angina, and angina pectoris
BMJ, November 19, 1994; 309(6965): 1343 - 1350.
[Full Text]


Home page
JWatch GeneralHome page
ANGIOPLASTY VS. THROMBOLYSIS FOR ACUTE MI
Journal Watch (General), April 22, 1994; 1994(422): 4 - 4.
[Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1994 by the American College of Cardiology Foundation.